223 related articles for article (PubMed ID: 35605011)
1. Plasma antibodies from humans infected with zoonotic simian foamy virus do not inhibit cell-to-cell transmission of the virus despite binding to the surface of infected cells.
Couteaudier M; Montange T; Njouom R; Bilounga-Ndongo C; Gessain A; Buseyne F
PLoS Pathog; 2022 May; 18(5):e1010470. PubMed ID: 35605011
[TBL] [Abstract][Full Text] [Related]
2. An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.
Lambert C; Batalie D; Montange T; Betsem E; Mouinga-Ondeme A; Njouom R; Gessain A; Buseyne F
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894477
[TBL] [Abstract][Full Text] [Related]
3. Potent neutralizing antibodies in humans infected with zoonotic simian foamy viruses target conserved epitopes located in the dimorphic domain of the surface envelope protein.
Lambert C; Couteaudier M; Gouzil J; Richard L; Montange T; Betsem E; Rua R; Tobaly-Tapiero J; Lindemann D; Njouom R; Mouinga-Ondémé A; Gessain A; Buseyne F
PLoS Pathog; 2018 Oct; 14(10):e1007293. PubMed ID: 30296302
[TBL] [Abstract][Full Text] [Related]
4. Cocirculation of Two env Molecular Variants, of Possible Recombinant Origin, in Gorilla and Chimpanzee Simian Foamy Virus Strains from Central Africa.
Richard L; Rua R; Betsem E; Mouinga-Ondémé A; Kazanji M; Leroy E; Njouom R; Buseyne F; Afonso PV; Gessain A
J Virol; 2015 Dec; 89(24):12480-91. PubMed ID: 26446599
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.
Dynesen LT; Fernandez I; Coquin Y; Delaplace M; Montange T; Njouom R; Bilounga-Ndongo C; Rey FA; Gessain A; Backovic M; Buseyne F
PLoS Pathog; 2023 Apr; 19(4):e1011339. PubMed ID: 37093892
[TBL] [Abstract][Full Text] [Related]
6. Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates.
Switzer WM; Bhullar V; Shanmugam V; Cong ME; Parekh B; Lerche NW; Yee JL; Ely JJ; Boneva R; Chapman LE; Folks TM; Heneine W
J Virol; 2004 Mar; 78(6):2780-9. PubMed ID: 14990698
[TBL] [Abstract][Full Text] [Related]
7. Frequent and recent human acquisition of simian foamy viruses through apes' bites in central Africa.
Betsem E; Rua R; Tortevoye P; Froment A; Gessain A
PLoS Pathog; 2011 Oct; 7(10):e1002306. PubMed ID: 22046126
[TBL] [Abstract][Full Text] [Related]
8. Naturally acquired simian retrovirus infections in central African hunters.
Wolfe ND; Switzer WM; Carr JK; Bhullar VB; Shanmugam V; Tamoufe U; Prosser AT; Torimiro JN; Wright A; Mpoudi-Ngole E; McCutchan FE; Birx DL; Folks TM; Burke DS; Heneine W
Lancet; 2004 Mar; 363(9413):932-7. PubMed ID: 15043960
[TBL] [Abstract][Full Text] [Related]
9. In vivo cellular tropism of gorilla simian foamy virus in blood of infected humans.
Rua R; Betsem E; Montange T; Buseyne F; Gessain A
J Virol; 2014 Nov; 88(22):13429-35. PubMed ID: 25210185
[TBL] [Abstract][Full Text] [Related]
10. Foamy virus zoonotic infections.
Pinto-Santini DM; Stenbak CR; Linial ML
Retrovirology; 2017 Dec; 14(1):55. PubMed ID: 29197389
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of higher primate foamy viruses, including a new virus from a gorilla.
Bieniasz PD; Rethwilm A; Pitman R; Daniel MD; Chrystie I; McClure MO
Virology; 1995 Feb; 207(1):217-28. PubMed ID: 7871729
[TBL] [Abstract][Full Text] [Related]
12. Persistent zoonotic infection of a human with simian foamy virus in the absence of an intact orf-2 accessory gene.
Callahan ME; Switzer WM; Matthews AL; Roberts BD; Heneine W; Folks TM; Sandstrom PA
J Virol; 1999 Nov; 73(11):9619-24. PubMed ID: 10516073
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of the interferon response increase the replication of gorilla simian foamy viruses.
Couteaudier M; Calzada-Fraile D; Montange T; Gessain A; Buseyne F
Virology; 2020 Feb; 541():25-31. PubMed ID: 31826843
[TBL] [Abstract][Full Text] [Related]
14. New World simian foamy virus infections in vivo and in vitro.
Stenbak CR; Craig KL; Ivanov SB; Wang X; Soliven KC; Jackson DL; Gutierrez GA; Engel G; Jones-Engel L; Linial ML
J Virol; 2014 Jan; 88(2):982-91. PubMed ID: 24198412
[TBL] [Abstract][Full Text] [Related]
15. Case-Control Study of the Immune Status of Humans Infected With Zoonotic Gorilla Simian Foamy Viruses.
Gessain A; Montange T; Betsem E; Bilounga Ndongo C; Njouom R; Buseyne F
J Infect Dis; 2020 Apr; 221(10):1724-1733. PubMed ID: 31822908
[TBL] [Abstract][Full Text] [Related]
16. Characterization of blood-borne transmission of simian foamy virus.
Brooks JI; Merks HW; Fournier J; Boneva RS; Sandstrom PA
Transfusion; 2007 Jan; 47(1):162-70. PubMed ID: 17207245
[TBL] [Abstract][Full Text] [Related]
17. Viral latency in blood and saliva of simian foamy virus-infected humans.
Rua R; Betsem E; Gessain A
PLoS One; 2013; 8(10):e77072. PubMed ID: 24116202
[TBL] [Abstract][Full Text] [Related]
18. Zoonotic infection of Brazilian primate workers with New World simian foamy virus.
Muniz CP; Cavalcante LTF; Jia H; Zheng H; Tang S; Augusto AM; Pissinatti A; Fedullo LP; Santos AF; Soares MA; Switzer WM
PLoS One; 2017; 12(9):e0184502. PubMed ID: 28931021
[TBL] [Abstract][Full Text] [Related]
19. Role of neutralizing antibodies in controlling simian foamy virus transmission and infection.
Williams DK; Khan AS
Transfusion; 2010 Jan; 50(1):200-7. PubMed ID: 19719470
[TBL] [Abstract][Full Text] [Related]
20. Genetic characterization of simian foamy viruses infecting humans.
Rua R; Betsem E; Calattini S; Saib A; Gessain A
J Virol; 2012 Dec; 86(24):13350-9. PubMed ID: 23015714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
